Deerfield Management Company
Deerfield Management Company reported 72 stocks worth $8B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are Nuvalent Inc (26.5%), RVMD (5.6%) and PRAX (4.0%). Compared with Q1 2026, the fund opened new positions in MLYS, BSX and PBLS, added to RVMD, LEGN and GMAB, trimmed CNC, COGT and CELC and sold out of NBIX, KYMR and CMPX.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | NUVALENT INC | $2.1B | 26.5% | 17.2M | No change | 8 of 8 | |
| 2 |  RVMD Revolution Medicines Inc | $448M | 5.6% | 2.4M | +95K (+4%) | 8 of 8 | |
| 3 |  PRAX Praxis Precision Medicines I | $323M | 4.0% | 963K | No change | 6 of 8 | |
| 4 |  VTRS Viatris Inc | $321M | 4.0% | 20.2M | No change | 8 of 8 | |
| 5 |  CNC Centene Corp Del | $315M | 3.9% | 4.9M | −1M (−17%) | 8 of 8 | |
| 6 |  UTHR United Therapeutics Corp Del | $248M | 3.1% | 457K | No change | 6 of 8 | |
| 7 |  LEGN Legend Biotech Corp | $235M | 2.9% | 8.1M | +450K (+6%) | 7 of 8 | |
| 8 |  COGT Cogent Biosciences Inc | $194M | 2.4% | 5M | −4M (−45%) | 8 of 8 | |
| 9 |  GMAB Genmab A/s | $189M | 2.4% | 6.9M | +4.4M (+179%) | 2 of 8 | |
| 10 |  BKD Brookdale SR Living Inc | $187M | 2.3% | 11.6M | No change | 8 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
CATALYST PHARMACEUTICALS INC | $97.6M | 3.9M |
 NBIX Neurocrine Biosciences Inc | $80.4M | 610K |
DAY ONE BIOPHARMACEUTICALS I | $79.8M | 3.7M |
ENHABIT INC | $66.9M | 4.7M |
 KYMR Kymera Therapeutics Inc | $46.7M | 561K |
🔒 Free account: see all 12.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Deerfield Management Company 13F FAQ
What does Deerfield Management Company own?
Deerfield Management Company reported 72 stocks worth $8B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are Nuvalent Inc (26.5%), RVMD (5.6%) and PRAX (4.0%). The table above lists every position in the filing (the top 10 without an account).
What did Deerfield Management Company buy and sell in Q2 2026?
Compared with Q1 2026: 11 new positions, 13 added to, 11 trimmed and 12 sold out. New positions include MLYS, BSX and PBLS. It sold all of NBIX, KYMR and CMPX.
When will Deerfield Management Company file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Deerfield Management Company's portfolio worth?
The Q2 2026 filing reports $8B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.